The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

$1.55 billion corporate bond offering for Reynolds American Inc.
Represented Reynolds American Inc., holding company for tobacco manufacturers R.J. Reynolds Tobacco Company and American Snuff Company, LLC, in its more
Covad Communications v. BellSouth Corporation (antitrust litigation in Atlanta federal district court)
Served as lead in-house counsel representing BellSouth in this significant antitrust case, which raised issues under essential facilities doctrine more
Product liability defense for leading pharmaceuticals manufacturer
Served as national counsel for leading pharmaceuticals manufacturer in multi-district litigation and individual product liability lawsuits more
Real estate acquisition for one of the world's premiere commercial real estate companies
The firm served as lead counsel in representing one of the world's premiere commercial real estate companies in a real estate acquisition from a more